India set to temper trial compensation rules
This article was originally published in Scrip
Executive Summary
India is expected to announce significant amendments to its controversial trial compensation rules including clarifications on payments in case of injury or death due to an investigational product not having its intended therapeutic effect, or due to a placebo-controlled trial.